Concepedia

Agnieszka K. Bischoff

AK

8

Publications

221

Citations

8

H-Index

2008

Active since

Affiliations

AbbVie (United States)(Current)

Abbott (United Kingdom)

Tianjin Economic-Technological Development Area

AbbVie (Germany)

Abbott Fund

Agnieszka K. Bischoff is an author at AbbVie (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2008–2023

8

Publications

8

Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody–Drug Conjugate Payloads

Adrian D. Hobson, Michael J. McPherson, Wendy Waegell et al. · Journal of Medicinal Chemistry · 2022 · 39 citations

, , +22

Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3

Martin E. Hayes, Grier A. Wallace, Pintipa Grongsaard et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 38 citations · Full text

, , +9

Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate

Adrian D. Hobson, Michael J. McPherson, Martin E. Hayes et al. · Journal of Medicinal Chemistry · 2022 · 37 citations

Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-α production

Kevin P. Cusack, Hamish Allen, Agnieszka K. Bischoff et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

, , +7

Discovery of thieno[2,3-c]pyridines as potent COT inhibitors

Dawn M. George, Michael Friedman, Hamish Allen et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text

, , +7

Rows per page

1–5 of 8